A single amino acid variation in the equine herpesvirus type 1 (EHV-1) DNA polymerase (Pol) (D752/N752) determines its neuropathogenic potential. Here, an EHV-1 strain RacL11 mutant with a deletion of Pol residue 752 was constructed. The deletion virus was then repaired to encode D752 or N752, respectively. The D752 mutant virus replicated with kinetics indistinguishable from those of D752 and N752 viruses. In addition, we could demonstrate that the deletion mutant was significantly more resistant to aphidicolin, a drug targeting Pol, compared with the N752 but not the D752 variant. In equine peripheral blood mononuclear cells, no significant difference was detected between the mutants with respect to cellular tropism or virus replication. The results demonstrated that amino acid residue 752 in EHV-1 Pol is not required for virus growth, and that only the N752 mutation confers a drug-sensitive phenotype to the virus.
1 harbours a 150 kb double-stranded DNA genome that is highly conserved among strains, with a nucleotide divergence of only 0.1 % (Nugent et al., 2006) . However, virulence of different strains can differ significantly, especially with respect to neuropathogenicity (Nugent et al., 2006) . It was found that only a minority of EHV-1 strains are capable of inducing neurological disorders, although all strains can cause respiratory disease and abortion (Mumford et al., 1987; Ostlund, 1993; Wilson, 1997) . Recently, epidemiological as well as reverse-genetic studies have shown that a single-nucleotide polymorphism at position 2254 (G/A2254) of open reading frame 30 (ORF30), encoding viral DNA polymerase (Pol), will lead to a variation at amino acid position 752 (D/N752), which is not only necessary but also sufficient for the virus's neuropathogenic potential (Goodman et al., 2007; Nugent et al., 2006; Van de Walle et al., 2009) . The D752 genotype, in contrast to N752, can induce higher levels of viraemia in horses in vivo. A significantly altered resistance to aphidicolin, a Pol-targeting antiviral drug that can competitively inhibit dNTP binding, was also reported (Goodman et al., 2007) .
Residue 752 of EHV-1 Pol corresponds to residue D751 of herpes simplex virus 1 and is located in the catalytic subunit of the essential enzyme (Liu et al., 2006; Wong et al., 1988) . The acidic residue is highly conserved in most alpha-, beta-and gammaherpesviruses (Nugent et al., 2006) . Whether the presence of this residue is essential for Pol function and replication of EHV-1 and other herpesviruses, however, is not clear. Here, we report the generation and characterization of an EHV-1 mutant with a deletion of residue 752 in the Pol of strain RacL11. We could show clearly that Pol residue 752 can be removed without any effect on virus growth. Interestingly, the increased sensitivity of an N752 mutant to the Poltargeting drug aphidicolin was not observed when residue 752 was absent, indicating that structural changes induced by asparagine at this location are critical for the function of the enzyme. It should be noted that no difference was found between the various genotypes with respect to lymphocyte tropism and replication.
Mutant viruses were based on wild-type strain RacL11, which was recovered from an infectious bacterial artificial chromosome (BAC) clone pL11, in which the green fluorescent protein-expressing mini-F sequence was inserted into the viral genome instead of gp2-encoding gene 71 (Rudolph et al., 2002) . Rabbit kidney (RK13) cells were maintained in Earle's minimum essential medium (EMEM) supplemented with 10 % heat-inactivated fetal bovine serum (FBS), 100 U penicillin ml 21 and 0.1 mg streptomycin ml
21
. Parental virus L11Dgp2 was obtained after transfection of the pL11 infectious clone into RK13 cells.
For all genetic manipulations, Escherichia coli strain GS1783 harbouring a temperature-sensitive Red recombination system of phage l (exo, bet and gam) and a gene encoding the endonuclease I-SceI in its genome was used. GS1783 cells contained the mini-F-based pL11 and were maintained in Luria-Bertani (LB) broth or on LB agar plates containing 30 mg chloramphenicol ml 21 . To delete residue 752 from DNA polymerase, two-step Redmediated en passant recombination (Tischer et al., 2006) was employed. Briefly, a primer pair (aa752-ep1/aa752-ep2; Table 1 ) was designed according to the nucleic acid sequences of Pol and the pEP-kan-S plasmid (Tischer et al., 2006) , which contains an I-SceI recognition site and the kanamycin-resistance gene (aphA1). The 59 ends of the primers carry homology arms of 40-50 bp identical to the sequences on either side of nucleic acid positions 2254-2256 in the EHV-1 Pol gene (ORF30). Standard PCR was performed using pEP-kan-S as the template, and the aphA1 gene with an additional 50 bp of identical sequences located upstream and downstream of the resistance gene, as well as the unique I-SceI recognition site located upstream of aphA1, was amplified. The amplicon was purified, digested with DpnI to remove residual template and electroporated into GS1783 cells harbouring pL11. Electroporation was performed in 1 mm cuvettes with settings of 1.8 kV, 200 V and 25 mF (BioRad). After kanamycin-resistant clones were obtained, recombinant intermediate BAC DNA was isolated by alkaline lysis and digested with HindIII. DNA fragments were separated by 0.8 % agarose gel electrophoresis and stained with ethidium bromide to examine the restrictionenzyme patterns. By adding 1 % arabinose to bacterial cultures, expression of the homing endonuclease I-SceI was induced, resulting in the cleavage of the I-SceI restriction site. A second recombination followed, ultimately leading to the excision of the kanamycin cassette and the construction of pL11-D752. Using the same strategy, D752 and N752 mutants were constructed from pL11-D752 using oligonucleotides D752-ep1/D752-ep2 and N752-ep1/N752-ep2, introducing the corresponding SNP, asparagine (N752) or aspartic acid (D752), into the deletion mutant.
Restriction fragment-length polymorphism (RFLP) analyses showed that no gross rearrangements occurred during mutagenesis (Fig. 1a) . A 780 bp ORF30 (Pol) fragment covering the point mutation was amplified from BAC DNA and reconstituted virus using sequencing primers poly1 and poly2 (Table 1) . The nucleotide polymorphisms resulting in absence of residue 752 or presence of N or D at the position were confirmed by sequencing using an ABI 3730 automated capillary sequencer (Applied Biosystems) 
with an ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction kit version 3.1 (StarSEQ) (Fig. 1b) .
Reconstitution of Pol variants was achieved by transfection of 2 mg BAC DNA into RK13 cells (Rudolph et al., 2002) . On day 2 after transfection, green plaques induced by L11D752gp2 were detected under a fluorescence microscope. The revertant viruses (L11D752Dgp2 and L11N752Dgp2) and parental virus L11Dgp2 were recovered. Pol fragments were amplified from virus DNA using primers poly1 and poly2 and sequenced. Sequence analysis confirmed that residue 752 in the Pol of L11D752gp2 was not repaired during virus replication, which indicated clearly that residue 752 is not required for virus growth in vitro (data not shown).
To compare the in vitro growth properties of L11D752gp2 with those of parental virus and the D752/N752 mutants, plaque areas and single-step growth kinetics were determined. Plaque areas were measured after infection of RK13 cells seeded in a six-well plate at an m.o.i. of 0.0001 and overlay with 1.5 % methylcellulose in EMEM-2 % FBS at 1 h post-infection (p.i.). For each virus, 50 plaques were photographed at 3 days p.i. and mean plaque sizes were analysed by using ImageJ software (http://rsb.info.nih.gov/ ij/). Plaque areas of the Pol variants were compared with those of parental virus L11Dgp2, which were set to 100 %. Mean percentages and SD were calculated from three independent experiments. The results showed that L11D752gp2 was able to grow with plaque sizes that were indistinguishable (P50.27; Student's t-test) from those of wild-type RacL11 and the D752/N752 revertants (Fig. 2a) .
For determining single-step growth kinetics, RK13 cells seeded in 24-well plates were infected at an m.o.i. of 3. The viruses were allowed to attach for 1 h at 4 uC, followed by a penetration step of 1.5 h at 37 u C. After washing twice with 16 PBS, infected cells were treated with ice-cold citratebuffered saline (pH 3.0) for 3 min to remove residual virus. At different time points (0, 4, 8, 12, 24, 36, 48 h p.i.) , supernatants and cells were collected separately. Extracellular and cell-associated virus titres were determined by using plaque assays. Single-step growth curves were computed from three independent experiments. Extracellular and cell-associated virus titres of L11D752gp2 were identical to those of parental virus and the D/N752 Pol variants (Fig. 2b) , demonstrating that the absence of residue 752 did not impair virus growth in vitro.
The D752 to N752 mutation in Pol resulted in a significantly reduced resistance of EHV-1 to aphidicolin (Goodman et al., 2007) . To compare the susceptibility of L11D752gp2 to aphidicolin with that of the Pol D/N752 variants, drug-sensitivity assays were performed. RK13 cells were infected with the L11D752gp2, L11D752Dgp2 or L11N752Dgp2 viruses, as well as parental virus L11Dgp2, at an m.o.i. of 0.01. After virus adsorption for 2 h at 37 u C, cells were washed twice with PBS and incubated with 1 ml fresh EMEM-1 % FBS containing different concentrations of aphidicolin for 2 days. Virus titres were then determined on fresh RK13 cells using 10-fold serial dilutions of virus progeny and compared with the control, which was not treated with aphidicolin and set to 100 %. It could be shown that the D752 mutant was significantly more resistant to aphidicolin than the Pol N752 mutant at all concentrations of the drug (P¡0.016; one-way ANOVA). When compared with wild type and the D752 revertant, the D752 mutant also proved to be more resistant to aphidicolin, but the observed increase in resistance was not statistically significant (P.0.05; one-way ANOVA) (Fig. 2c) .
To further determine whether the deletion of residue 752 would affect virus replication in peripheral blood mononuclear cells (PBMCs), flow cytometry and quantitative (q)PCR were used to investigate the course of virus infection. Equine PBMCs were isolated by density-gradient centrifugation over Biocoll 1077 (Biochrom AG) from heparinized blood. Immediately after isolation, 1610 6 PBMCs were infected with the deletion mutant, D/N752 revertants or the parental virus L11Dgp2 at an m.o.i. of 1 and incubated at 37 u C for 24 or 48 h. For flow cytometry, cell populations were collected at different time points p.i. and characterized by using a FACScalibur (Becton 
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Dickinson) after staining with mouse monoclonal antibodies recognizing CD4, CD8, CD14 or B cells (Goodman et al., 2007;  antibodies kindly provided by Bettina Wagner, Cornell University, NY, USA) and an Alexa Fluor 647-conjugated goat anti-mouse IgG antibody (Invitrogen).
The experiment was performed in two independent replicates and each sample was also tested in duplicate for each experiment. For qPCR, PBMCs from each time point were washed three times with PBS to remove viruses in the supernatant, and genomic DNA was extracted by using an E-Z 96 Blood DNA kit (Omega). qPCR was then performed by using the 7500-Fast real-time PCR system (Applied Biosystems) in a total volume of 20 ml and standard cycling conditions, exactly as described earlier (Goodman et al., 2007) . The EHV-1 IR6 (gene 67) and the horse b2-microglobulin (b2M) genes were used to quantify virus genome copies normalized to host genome copies using primers and MGB probes described earlier (Goodman et al., 2006 (Goodman et al., , 2007 . pL11 was used as the virus standard and a BAC clone of equine chromosome ECA-1 containing the b2M gene (kindly provided by Dr D. Antczak, Cornell University, NY, USA) was used for host genome-copy quantification. Virus genome copies were calculated based on 1610 6 b2M gene copies.
The results (Fig. 2d, e) showed that all tested viruses were capable of infecting lymphocytes with similar efficiencies. Monocytes (positive for CD14) were found to be the prevalent subpopulation infected with L11 Pol mutants, with .60 % of CD14 + cells infected at 48 h p.i. (Fig. 2e) . Only 1.4-1.6 % of CD4 + and 3.7-4.7 % of CD8 + T-cell subpopulations were infected at the same time. As for the virus genome copies, no significant differences (P¢0.07) were detected between the Pol mutants at either 24 or 48 h p.i. (Fig. 2d) . These results indicated that a single mutation of residue 752 in DNA polymerase of EHV-1 could not certainly, at least for RacL11, lead to altered replication efficiency in PBMCs.
The virus Pol has been confirmed recently to be indispensable for the replication of EHV-1 in vitro (G. Ma & N. Osterrieder, unpublished data) . It is predicted by modelling that residue 752 of EHV-1 lies between the conserved domains II and VI that are followed by the conserved motif A, a portion of the dNTP-binding cleft within the active site (Delarue et al., 1990; Liu et al., 2006) . Residue 752 was hypothesized to be able to influence Pol function via direct or indirect effect on dNTP usage and/or catalysis, which might be the explanation for the fact that Pol D/N752 variants differ in their sensitivity to aphidicolin in vitro and their ability to replicate in vivo (Goodman et al., 2007; Van de Walle et al., 2009) . We confirmed here that the highly conserved residue 752 in the essential DNA polymerase of EHV-1 is not required for virus replication, nor does a deletion have a measurable effect on virus replication in RK13 cell culture. These results suggest that residue 752 does not have a direct role in chain elongation per se, and thus a function of the residue on Pol processivity is highly likely. It is tempting to Role of residue 752 of EHV-1 polymerase speculate that, like the D/N752 substitution, the deletion of residue 752 alters the domain structure outside the Pol catalytic site. This would indirectly result in a reduced sensitivity of the D752 mutant to aphidicolin compared with the N752 variant, and the deletion mutant would be much more similar to the D752 genotype.
Previous studies based on EHV-1 strain Ab4 showed that the D/N752 substitution altered virus tropism to lymphocytes such that D752 preferentially infected CD4 + T lymphocytes, whereas N752 was able to infect monocytes and B cells more efficiently (Goodman et al., 2007) . In this study, we failed to detect different preferences of L11-based Pol mutants, even for the D752 deletion. The different behaviour of Ab4 and RacL11 in PBMCs suggests that the effect of the mutation at residue 752 on virus replication in PBMCs is dependent on other viral factors. Compared with the genome of Ab4, RacL11 was found to harbour a deletion of 1285 bp at the extreme left terminus of the genome and a 339 bp in-frame deletion in the ICP0 homologue (G. Ma, N. Osterrieder & C. Lu, unpublished data). EHV-1 ICP0 is an early gene that was shown to be a potent transcriptional activator of all classes of EHV-1 promoters (Bowles et al., 1997) . Whether this deletion in RacL11 influences virus replication in PBMCs will be addressed in the future.
In conclusion, we have shown that residue 752 in the essential Pol of EHV-1 is not required for virus growth and that only the N752 mutation confers a drug-sensitive phenotype to the virus. The single mutation of RacL11 Pol residue 752 alone did not lead to altered virus replication in PBMCs, suggesting the involvement of other viral factors influencing the capability for efficient growth in blood cells.
